Caloxin 2A1 trifluoroacetate salt structure
|
Common Name | Caloxin 2A1 trifluoroacetate salt | ||
---|---|---|---|---|
CAS Number | 350670-85-8 | Molecular Weight | 1478.521 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 2095.7±65.0 °C at 760 mmHg | |
Molecular Formula | C64H91N19O22 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 1221.3±34.3 °C |
Use of Caloxin 2A1 trifluoroacetate saltCaloxin 2A1 is an extracellular plasma membrane Ca2+-ATPase (PMCA) peptide inhibitor. Caloxin 2A1 does not affect basal Mg2+-ATPase or Na+-K+-ATPase[1]. |
Name | L-Valyl-L-seryl-L-asparaginyl-L-seryl-L-asparaginyl-L-tryptophyl-L-prolyl-L-seryl-L-phenylalanyl-L-prolyl-L-seryl-L-serylglycylglycylglycinamide |
---|---|
Synonym | More Synonyms |
Description | Caloxin 2A1 is an extracellular plasma membrane Ca2+-ATPase (PMCA) peptide inhibitor. Caloxin 2A1 does not affect basal Mg2+-ATPase or Na+-K+-ATPase[1]. |
---|---|
Related Catalog | |
In Vitro | Caloxin 2A1 inhibits Ca2+-Mg2+-ATPase in human erythrocyte leaky ghosts, but it does not affect basal Mg2+-ATPase or Na+-K+-ATPase in the ghosts or Ca2+-Mg2+-ATPase in the skeletal muscle sarcoplasmic reticulum. Caloxin 2A1 also inhibits Ca2+-dependent formation of the 140-kDa acid-stable acylphosphate[1]. Caloxin 2A1 increases airway smooth muscle cells (ASMCs) apoptosis[2]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 2095.7±65.0 °C at 760 mmHg |
Molecular Formula | C64H91N19O22 |
Molecular Weight | 1478.521 |
Flash Point | 1221.3±34.3 °C |
Exact Mass | 1477.658569 |
LogP | -4.68 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.625 |
L-Valyl-L-seryl-L-asparaginyl-L-seryl-L-asparaginyl-L-tryptophyl-L-prolyl-L-seryl-L-phenylalanyl-L-prolyl-L-seryl-L-serylglycylglycylglycinamide |
Glycinamide, L-valyl-L-seryl-L-asparaginyl-L-seryl-L-asparaginyl-L-tryptophyl-L-prolyl-L-seryl-L-phenylalanyl-L-prolyl-L-seryl-L-serylglycylglycyl- |